Natalie Staplin

PhD

MRC PHRU Senior Statistician

Natalie is a Senior Statistician within the Renal Studies Group at the Clinical Trials Service Unit & Epidemiological Studies Unit (CTSU). She is also a lecturer on the MSc in Global Health Sciences. She joined CTSU in 2012 after completing an undergraduate degree in Mathematics with Actuarial Science and a PhD in Statistics. Her current research interests are epidemiological analyses of patients with chronic kidney disease to identify risk factors associated with vascular events or progression to end-stage renal disease. She is particularly interested in competing risks methodology and the use of directed acyclic graphs in observational analyses.

Recent publications

Apolipoprotein B, Triglyceride-Rich Lipoproteins, and Risk of Cardiovascular Events in Persons with CKD.
Journal article

Lamprea-Montealegre JA. et al, (2019), Clin J Am Soc Nephrol
Kidney disease trials for the 21st century: innovations in design and conduct.
Journal article

Herrington WG. et al, (2019), Nat Rev Nephrol
Effects of Sacubitril/Valsartan Versus Irbesartan in Patients With Chronic Kidney Disease.
Journal article

Haynes R. et al, (2018), Circulation, 138, 1505 - 1514
Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C Study) - results of a randomized controlled clinical trial.
Journal article

3C Study Collaborative Group None., (2018), Am J Transplant, 18, 1424 - 1434
Confounding is not the only bias influencing associations of adiposity with cardiovascular disease.
Journal article

Staplin N., (2018), Eur Heart J, 39, 1521 - 1522